Olsalazine-Related Diarrhoea: Does Rat Intestine Adapt in Vivo?

References

• Dick AP, Grayson MJ, Carpenter RG, Petrie A. Controlled trial of sulphasalazinc in the treatment of ulcerative colitis. Gut 1964; 5: 437–42
   PubMed Web of Science ®Google Scholar
• Truelove SC, Watkinson G, Draper G. Comparison of corticosteroid and sulphasalazinc therapy in ulcerative colitis. Br Med J 1962; 2: 1708–11
   PubMed Web of Science ®Google Scholar
• Dissanayake AS, Truelove SC. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin). Gut 1973; 14: 923–6
   PubMed Web of Science ®Google Scholar
• Riis P, Binder J, Kristensen M. The relapse preventing effect of methyl-salazosulphapyridine compared to salazosulpha-pyridine during long-term treatment of ulcerative colitis. Scand J Gastroenterol 1979; 14: 257–60
   PubMed Web of Science ®Google Scholar
• Taffet SL, Das KM. Sulfasalazine. Adverse effects and desensitisation. Dig Dis Sci 1983; 28: 833–42
   PubMed Web of Science ®Google Scholar
• Riley SA, Turnberg LA. Sulphasalazine and the aminosalicylates in the treatment of inflammatory bowel disease. Q J Med 1990; 278: 551–62
   Google Scholar
• Lauritsen K, Hansen J, Ryde M, Rask-Madsen J. Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis. Gastroenterology 1984; 86: 1496–1500
   PubMed Web of Science ®Google Scholar
• Van Hogezand RA. Pharmacokinetics of olsalazine and its metabolites. Scand J Gastroenterol 1988; 23: 17–20, Suppl 148
   Web of Science ®Google Scholar
• Wadworth AN, Fitton A. Olsalazine — a review of its pharmacodynamic and pharmacokinetic, properties, and therapeutic potential in inflammatory bowel disease. Drugs 1991; 41: 647–64
   PubMed Web of Science ®Google Scholar
• Ewe K, Echardt V, Kanzler G. Treatment of ulcerative colitis with olsalazine and sulphasalazine. Scand J Gastroenterol 1988; 23: 70–5, Suppl 148
   Web of Science ®Google Scholar
• Rao SS, Dundas SAC, Holdsworth CD, Cann PA, Palmer KR. Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study. Gut 1989; 30: 675–9
   PubMed Web of Science ®Google Scholar
• Willoughby CP, Cowan RE, Gould SR, Machell RJ, Stewart JB. Double-blind comparison of olsalazine and sulphasalazine for maintenance treatment of ulcerative colitis. Scand J Gastroenterol 1988; 23: 40–44, Suppl 148
   Web of Science ®Google Scholar
• Ireland A, Mason CH, Jewell DP. Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis. Gut 1988; 29: 835–7
   PubMed Web of Science ®Google Scholar
• Courtney MG, Numes D, Bergin C, Trimble V, O'Driscoll M. Olsalazine is significantly better than mesalazine in preventing relapse of ulcerative colitis. Am J Gastroenterol 1990; 85: 1274
   Google Scholar
• Courtney MG, Weir DG. Olsalazine in the treatment of ulcerative colitis. Scand J Gastroenterol 1988; 23: 83–5, Suppl 148
   PubMed Web of Science ®Google Scholar
• Hetzel DJ, Hanvahan HN, Chapman PJ. Olsalazine treatment in patients intolerant of sulphasalazine: the Australian experience. Scand J Gastroenterol 1988; 23: 89–94, Suppl 148
   Web of Science ®Google Scholar
• Sandberg-Gertzen H, Järnerot G, Kraaz W. Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties. Gastroenterology 1986; 90: 1024–30
   PubMed Web of Science ®Google Scholar
• Smits BJ. Open study of olsalazine in ulcerative colitis. Scand J Gastroenterol 1988; 23: 95, Suppl 148
   PubMed Web of Science ®Google Scholar
• Järnerot G. Clinical tolerance of olsalazine. Scand J Gastroenterol 1988; 23: 21–3, Suppl 148
   Web of Science ®Google Scholar
• Csaky TZ, Ho PM. Intestinal transport of D-xylose. Proc Soc Exp Biol Med 1965; 120: 403–8
   PubMedGoogle Scholar
• Schäfer SG, Forth W. Excretion of metals into the rat intestine. Biol Trace Elem Res 1983; 5: 205–17
   PubMedGoogle Scholar
• Bavister PH, Longnecker DE. Influence of anaesthetic agents on the survival of rats following acute ischaemia of the bowel. Br J Anaesth 1979; 51: 921–5
   PubMedGoogle Scholar
• Krebs HA, Henseleit K. Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe Seylers Z Physiol Chem 1932; 210: 33–66
   Google Scholar
• Wingate DL, Sandberg RJ, Phillips SF. A comparison of stable and 14C-labeled polyethylene glycol as volume indicators in the human jejunum. Gut 1972; 13: 812–5
   PubMed Web of Science ®Google Scholar
• Bergmeyer HU. Methods of enzymatic analysis.3rd ed. VHC, Weinheim 1983; Vol 6: 222–33
   Google Scholar
• Sachs L. Statistische Auswertungsmethoden.3rd ed. Springer, Berlin 1971
   Google Scholar
• Laursen LS, Stokholm M, Burkhave K, Rask-Madsen J, Lauritsen K. Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic, concentrations, serum values, and urinary excretion. Gut 1990; 31: 1271–6
   PubMedGoogle Scholar
• Goerg KJ, Wanitschke R, Gabbert H, Breiling J, Franke M, Meyer zum Büschenfelde KH. Azodisalicylate (azodisal sodium) causes intestinal secretion. Digestion 1987; 37: 79–87
   PubMed Web of Science ®Google Scholar
• Mohsen AOM, Mulvey D, Priddle JD, Parsons DS, Jewell DP. Effects of olsalazine in the jejunum of the rat. Gut 1987; 28: 346–52
   PubMed Web of Science ®Google Scholar
• Pamukcu R, Hanauer S, Chang EB. Effect of disodium azodisalicylate on electrolyte transport in rabbit ileum and colon in vitro. Gastroenterology 1988; 95: 975–81
   PubMedGoogle Scholar
• Wanitschke R, Goerg KJ, Jeschek B, Krok S. The effect of azodisalicylate on net electrolyte and water transfer in the intact healthy human colon [abstract]. Gastroenterology 1987; 92: 1685
   Google Scholar
• Sandberg-Gertzen H, Järnerot G, Burkhave K, Lauritsen K, Rask-Madsen J. Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 in subjects with permanent ileostomy. Gut 1986; 27: 1306–11
   PubMed Web of Science ®Google Scholar
• Fordtran JS, Rector FC, Jr, Carter W. The mechanism of sodium absorption in the human small intestine. J Clin Invest 1968; 47: 884–90
   PubMed Web of Science ®Google Scholar
• Binder HJ. Absorption and secretion of water and electrolytes by small and large intestine. Gastrointestinal disease. Pathophysiology, diagnosis, management. Part V. The small and large intestine: anatomy, physiology, and disease.4th ed., MH Sleisinger, JS Fordtran. Saunders, Philadelphia 1989; 1022–45
   Google Scholar
• Frizzell RA, Field M, Schultz G. Sodium coupled chloride transport by epithelial tissues. Am J Physiol 1979; 236(F1-F)8
   Google Scholar
• Turnberg LA. Potassium transport in the human small bowel. Gut 1971; 12: 811–8
   PubMedGoogle Scholar
• Foster ES, Hayslett JP, Binder HJ. Mechanism of active potassium absorption and secretion in the rat colon. Am J Physiol 1984; 246: G611–6
   Google Scholar
• Hopfer U. Kinetics of Na+-dependent D-glucosetransport. J Supramol Struct 1977; 7: 1–13
   PubMedGoogle Scholar
• Kimmich GA. Intestinal absorption of sugar. Physiology of the gastrointestinal tract, LR Johnson. Raven Press, New York 1981; 1035–61
   Google Scholar
• Hopfer U. Membrane transport mechanisms for hexoses and amino acids in the small intestine. Physiology of the gastrointestinal tract, LR Johnson. Raven Press, New York 1987; 1499–1526
   Google Scholar
• Chang EB, Wang NS, Rao MC. Phorbol ester stimulation of active anion secretion in the intestine. Am J Physiol 1985; 249: C356–61
   Google Scholar
• Gionchetti P, Guarnieri C, Campieri M, et al. Scavenger effect of, sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical scavenger generation. Dig Dis Sci 1991; 36: 174–8
   PubMed Web of Science ®Google Scholar